C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
C-Tech Analytical Solutions
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!
Get a free Nalgene bottle when you send us an enquiry!

Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Epygenix Therapeutics Announces FDA Acceptance of IND to Initiate a Clinical Trial of EPX-100 to Treat Lennox-Gastaut Syndrome

Monday, August 30, 2021

Epygenix Therapeutics Inc a clinical stage biopharmaceutical company focused on rare and intractable genetic epilepsy announced today that the US Food and Drug Administration FDA has accepted the Companys Investigational New Drug IND application to i...

Ironwood Pharmaceuticals Announces FDA Approval of Revised LINZESS® (linaclotide) Label

Friday, August 27, 2021

Ironwood Pharmaceuticals Inc a GIfocused healthcare company today announced that the US Food and Drug Administration FDA approved a revised label for LINZESS linaclotide based on clinical safety data that has been generated thus far in pediatric stud...

FDA Clears Thermo Scientific EliA SmD(P)-S Test For Use In U.S.

Friday, August 27, 2021

Thermo Scientific EliA SmDPS test has been cleared by the US Food Drug Administration FDA for aiding the diagnosis of Systemic Lupus Erythematosus SLE the most common type of lupus This new test enhances specificity without sacrificing sensitivity l...

Provectus Algae Expands into New Large-Scale Microalgae Biomanufacturing Facility

Thursday, August 26, 2021

Provectus Algae an Australian biotechnology platform company specialising in the biomanufacturing of highvalue compounds for a wide array of industries using microalgae announced they will be expanding into an additional largescale manufacturing faci...

FSD Pharma Announces Definitive Agreement to Acquire Lucid Psycheceuticals

Thursday, August 26, 2021

FSD Pharma Inc a life sciences holding company dedicated to building a portfolio of assets and biotech solutions in legal psychedelics and medical cannabis announced today it has entered a definitive agreement to acquire of the issued and outstandin...

FLEXcon Announces Global Launch of New PHARMcal® Portfolio for Pharmaceutical Labeling

Wednesday, August 25, 2021

FLEXcon Company Inc an innovator in adhesive coating and laminating today announced the relaunch of its FLEXcon PHARMcal line of track and trace solutions featuring engineered films with exceptional printability robust adhesion and optimized liners f...

InDex Pharmaceuticals receives FDA clearance to start the phase III study CONCLUDE with cobitolimod

Wednesday, August 25, 2021

InDex Pharmaceuticals Holding AB publ today announced that the US Food and Drug Administration FDA has given clearance to start the phase III clinical study CONCLUDE in the United States The study will evaluate the efficacy and safety of the firstinc...

BioDuro-Sundia Acquires US-based Phase III/Commercial Drug Product Manufacturing Facility

Tuesday, August 24, 2021

BioDuroSundia a leading drug discovery and development services organization backed by Advent International announced today it has entered into a definitive agreement to acquire a ft commercial oral solid dose manufacturing facility located at Fair...

Pfizer to Acquire Trillium Therapeutics Inc.

Tuesday, August 24, 2021

Pfizer Inc and Trillium Therapeutics Inc announced that the companies have entered into a definitive agreement under which Pfizer will acquire Trillium a clinical stage immunooncology company developing innovative therapies for the treatment of cance...

BeiGene Announces Acceptance of a Supplemental Biologics License Application in China for Tislelizumab in Nasopharyngeal Cancer

Monday, August 23, 2021

BeiGene Ltd a global biotechnology company focused on developing and commercializing innovative medicines worldwide today announced that the Center for Drug Evaluation CDE of the China National Medical Products Administration NMPA has accepted a supp...

Latest Issue
Get instant
access to our latest e-book
Saving Money, Saving Time In Pharma Operations